<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Akero Therapeutics, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Akero Therapeutics, Inc.

    Akero aims to develop and deliver transformational medicines to patients with high unmet medical need. Akero’s current focus is advancing our lead program, AKR-001, to provide a powerful new therapy for patients with NASH (non-alcoholic steatohepatitis). Akero is led by industry veterans with decades of experience delivering innovative medicines to patients. We are united in our commitment to developing transformational new therapies for NASH and other serious metabolic diseases. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $432,700,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Andrew Cheng
    • FOUNDED
      2017
    • EMPLOYEES
      0-10
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    Meridian Bioscience Inc.

    Meridian Bioscience Inc.

    Meridian is a fully integrated life science company that develops, manufactures, m...

    Meridian is a fully integrated life science com...

    Filing Type:    PU
    LifeBridge 10000, LLC

    LifeBridge 10000, LLC

    LifeBridge 10000, LLC specializes in extending and improving the quality of life f...

    LifeBridge 10000, LLC specializes in extending ...

    Amount Raised:    $23,091.00
    Fundraising Status:    EC
    Filing Type:    CF
    Surmodics, Inc.

    Surmodics, Inc.

    Following two acquisitions of Creagh Medical and NorMedix – recognized innovator...

    Following two acquisitions of Creagh Medical an...

    Filing Type:    PU
    Spring Bank Pharmaceuticals, Inc.

    Spring Bank Pharmaceuticals, Inc.

    Spring Bank is a clinical-stage biopharmaceutical company engaged in the discovery...

    Spring Bank is a clinical-stage biopharmaceutic...

    Filing Type:    PU
    Exicure, Inc.

    Exicure, Inc.

    Exicure, Inc. is a clinical stage biotechnology company developing a new class of ...

    Exicure, Inc. is a clinical stage biotechnology...

    Filing Type:    PU
    Seelos Therapeutics, Inc.

    Seelos Therapeutics, Inc.

    Seelos Therapeutics, Inc. (Nasdaq: SEEL) is a responsibly-driven company focused o...

    Seelos Therapeutics, Inc. (Nasdaq: SEEL) is a r...

    Filing Type:    PU
    Cara Therapeutics, Inc.

    Cara Therapeutics, Inc.

    Cara Therapeutics is a clinical-stage biopharmaceutical company focused on develop...

    Cara Therapeutics is a clinical-stage biopharma...

    Filing Type:    PU
    Albireo Pharma, Inc.

    Albireo Pharma, Inc.

    Albireo is a clinical-stage biopharmaceutical company focused on the development a...

    Albireo is a clinical-stage biopharmaceutical c...

    Filing Type:    PU
    CymaBay Therapeutics Inc.

    CymaBay Therapeutics Inc.

    We are a clinical-stage biopharmaceutical company focused on developing and provid...

    We are a clinical-stage biopharmaceutical compa...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.